Claim OwnershipA pinch of salt - A podcast by ERA
Subscribed: 26Played: 739
Subscribe
© 2026 A pinch of salt - A podcast by ERA
Description
A pinch of salt is the official ERA podcast dedicated to nephrology.
Each month, we'll release three episodes with nephrologists and other physicians discuss advances in clinical practice and renal medicine.
Hosts: Andrej Skoberne and George Kosmadakis
121 Episodes
Reverse
In this very interesting episode with Thomas Wilkinson we talk about sarcopenia — its prevalence, the outcomes associated with it, the available tools for screening and assessment, the most effective interventions, and the importance of a multidisciplinary approach to care.
In this episode we’ll be talking to Tamara Jemcov, the current president of the Vascular Access Society, about novelties in the field of vascular access. If you haven’t checked out the programme from the last Vascular Access Congress which was held in 2025 Padova, you should take look. The field is really expanding and growing, and Tamara discussed the new approaches that were presented at the Congress. We also talked about the appropriate timing of vascular access construction, the immensely...
In this episode we will be talking with Thomas Rimmele, an expert in treating acute kidney injury in the ICU, about the role of the new extracorporeal adsorption techniques in ICU patients. We’ll be discussing who are the candidates, when to start treatment, how long should a single session last, how long should we continue doing it, which parameters to check to see if we are successful or not and much, much more. If you are unsure on how to use these techniques to benefit the sickest of pati...
In this episode of A pinch of salt we’ll be talking to Paul Cockwell about patient-reported outcomes in clinical practice. You may or may not be aware of these issues and their importance but one might argue, and we certainly would, that every doctor should be mindful of what their patients consider to be an important outcome and whether they are achieving it or not. Paul is a champion of this field, and he provided some very useful pointers on how a beginner in this field might get to know i...
In this episode of A pinch of salt, we welcome Pierre Delanaye for a forward-looking discussion on how we should assess kidney function in 2026. Together, we explore the strengths and limits of today’s GFR equations (MDRD, CKD-EPI, cystatin C-based approaches), the promise of emerging biomarkers and AI-driven tools, and the crucial question of fairness and accuracy across diverse populations.
Join A pinch of salt, as we sit down with David Jayne to trace the rapid transformation of ANCA-associated vasculitis care. From the historic cyclophosphamide–glucocorticoid backbone to biologics like rituximab and newer targeted strategies such as complement inhibition (including avacopan), this episode unpacks how clinicians can balance efficacy, safety, and quality of life—while looking ahead to what may define the next decade of treatment.
In this episode of A pinch of salt, Allon N. Friedman will talk about possibly the hottest topic in medicine at this moment – the treatment of obesity, with a particular focus on treating the CKD population. Obesity is finally being recognized as a disease and not merely an unfortunate, somewhat shameful consequence of personalities with weak minds and lack of willpower. But how do we treat it? Does changing lifestyle have any impact, should everybody start taking weight lowering medications,...
In this episode of A pinch of salt, Shuchi Anand will talk about chronic kidney disease of unknown etiology, the mysterious kidney disease that is devastating some agricultural communities in hot environments. Dr Anand will talk about what might be causing this disease, does a kidney biopsy help, is it mandatory, and how to treat these patients both on the individual level and on the population level to tackle this disease locally and globally. Learn more about this true medical mystery, with...
In this episode of A pinch of salt, Beatriz Sanchez Alamo will talk about tubulointerstitial nephritis (TIN), the Cinderella of nephrology, a beautiful and interesting topic that is not easily noticeable in congresses and webinars. Some recent data looking at long-term prognosis has shown that patients with TIN might have a long-term prognosis that is comparable to lupus nephritis and ANCA vasculitis. Are we ignoring TIN and if so, what should we be doing differently? In this episode we’ll be...
In this episode we will be talking to Giovanni Tripepi, an expert in biostatistics. Medicine is not just an art but also a science grounded in biostatistics, which is why it is crucial to understand it in order to conduct and interpret research properly. In this episode you will hear about the most common mistakes made by medical researchers when planning a project, the most common mistakes when interpreting data, why a p-value below 0.05 is not always significant and a whole lot more. By the...
In this episode we will be talking to Luca Quartuccio, a rheumatologist and a renowned expert in cryoglobulinemia. You will hear about how we diagnose cryoglobulinemic vasculitis, whether we can have cryoglobulinemia without vasculitis, the types of cryoglobulinemia and their clinical significance, how to tackle secondary cryoglobulinemia with hepatitis C or B, first line therapy, the role of plasma exchange and maintenance therapy and much, much more. Dedicated to everybody who takes care of...
In this episode we had the honor and privilege to talk to Camille Kotton, a world-renowned expert in BK nephropathy. The fabulous recent International Consensus Guidelines have been a breakthrough in this field, and we will talk about all the new approaches and recommendations described in them, including how to screen for BK nephropathy, how to act when screening is positive, when to do a biopsy, and different strategies of changing immunosuppression. We’ll also be talking about very difficu...
In this episode, Charles Ferro from Birmingham, United Kingdom, presents the ERA’s Strong Kidneys Task Force. Learn how this Task Force is raising global awareness about kidney health, building partnerships with national societies, and inspiring people to take care of their kidneys.
In this episode, we head to New Orleans, USA where Juan Carlos Q. Velez helps us unravel the mystery of hepatorenal syndrome. We’ll explore its mechanisms, the two distinct types, and evolving treatment strategies that might finally improve outcomes for patients with advanced liver disease.
In this episode, we chat with Alice Sabatino from the Karolinska Institute in Stockholm, Sweden about diet and hyperkalemia. How have new potassium binders and RAAS inhibitors changed the way we manage potassium? And do patients really need to cut out fruits and vegetables anymore? Alice shares practical diet tips and fresh insights from recent research.
Comments
Download from Google Play
Download from App Store
United States